RTOG Foundation Master Service Agreement for Participation in Foundation Research: RTOG 3501 Tryhard: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb) for Non-HPV Locally Advanced Head and Neck Cancer with Concurrent Chemoradiation

Grant

Date/time Interval

  • October 1, 2012 - June 30, 2022
  • Total Award Amount

  • 36400.00
  • Direct Costs

  • 28889.00
  • Sponsor Award Id

  • Contributor

  • Burnett, Omer   Investigator  
  • De Los Santos, Jennifer   Principal Investigator  
  • Dobelbower M.D., Michael   Investigator  
  • Fiveash M.D., John   Investigator  
  • Jacob M.D., Rojymon   Investigator  
  • Keene M.D., Kimberly   Investigator  
  • Kim M.D., Robert   Investigator  
  • Meredith, Ruby   Investigator  
  • Spencer M.D., Sharon   Investigator  
  • Willey M.D., Ph.D., Christopher   Investigator  
  • Yang M.D., Ph.D., Eddy   Investigator